Welcome to our dedicated page for Curiositystream SEC filings (Ticker: CURI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to CuriosityStream Inc. (NASDAQ: CURI) SEC filings, giving investors and researchers a primary source view of the company’s regulatory disclosures. As a Delaware corporation and emerging growth company, CuriosityStream files annual reports, quarterly reports, current reports, proxy materials, and registration-related documents with the U.S. Securities and Exchange Commission.
Through these filings, readers can examine details of CuriosityStream’s factual media and licensing business, including how it describes its subscription services, content licensing activities, and AI dataset partnerships. Annual and quarterly reports typically include discussions of revenue composition, use of non-GAAP measures such as Adjusted EBITDA and Adjusted Free Cash Flow, risk factors, and management’s analysis of its operations in the motion picture and video production industry.
Current reports on Form 8-K, such as those referenced in recent disclosures, document material events including secondary offerings by selling stockholders, outcomes of annual stockholder meetings, and other corporate actions. Proxy statements provide information on matters submitted to stockholders, such as director elections, incentive plan amendments, and auditor ratification.
On Stock Titan, CuriosityStream filings are updated as they are made available through EDGAR, and AI-powered summaries help explain the key points of lengthy documents like 10-K and 10-Q reports. Users can quickly identify important topics, while still having access to the full text for detailed review. Filings related to equity offerings, shelf registrations, and governance matters are also accessible, supporting deeper analysis of CURI’s capital structure and shareholder decisions.
For those monitoring insider activity, compensation policies, or governance changes, this page serves as a central hub to explore CuriosityStream’s official SEC submissions, with AI tools designed to make complex regulatory language easier to understand.
CuriosityStream (CURI) disclosed an insider transaction as Chief Financial Officer P. Brady Hayden reported a sale of 17,508 shares of common stock on 11/06/2025. The sale was executed under a Rule 10b5-1 plan that Mr. Hayden entered into on May 30, 2025.
The shares were sold at a weighted average price of $3.867, with individual trades ranging from $3.76 to $4.05. Following the transaction, Mr. Hayden beneficially owned 20,817 shares held by the P. Brady Hayden Revocable Trust and 25,000 shares held by Plan Z, LLC.
CuriosityStream (CURI): General Counsel Rebecca Reed reported a sale of common stock in a Form 4 filing. On 11/06/2025, she sold 4,559 shares at $4.06 per share, executed under a pre‑arranged Rule 10b5‑1(c) trading plan entered on May 21, 2025. Following the transaction, she directly beneficially owns 26,774 shares.
This filing discloses an officer’s planned stock sale and her updated direct holdings.
Rebecca R. Reed, General Counsel and director of CuriosityStream Inc. (ticker shown as CURI), reported that 43 restricted stock units (RSUs) granted July 19, 2021 vested on September 19, 2025 and were converted one-for-one into 43 shares of common stock. The filing also shows the company withheld 15 shares$5.27, leaving 31,333 sharesSeptember 23, 2025. The record shows routine insider vesting and corresponding tax withholding; no other transactions or derivative positions were reported.
Jonathan Huberman, a director of CuriosityStream Inc. (CURI), reported sales of common stock on 09/05/2025. The Form 4 shows 25,000 shares sold at a weighted average price of $4.6095 (sales ranged $4.60–$4.655) and an additional 144,700 shares sold, for a total of 169,700 shares disposed on that date. After these transactions, 211 LV LLC, of which Mr. Huberman is the managing member, is reported to beneficially own 1,308,576 shares indirectly. The filing was signed on behalf of Mr. Huberman by an attorney-in-fact on 09/09/2025. The filer disclaims beneficial ownership except to the extent of any pecuniary interest.
CuriosityStream Inc. (CURI) Form 144 shows a proposed sale of 50,000 common shares through Needham and Company on NASDAQ with an aggregate market value of $230,000.00. The shares were originally acquired on 10/14/2020 by SPAC conversion. The filer, identified in recent sale records as Jonathan Huberman, completed multiple disposals in late August and early September totaling 100,000 shares and gross proceeds of approximately $451,700.95. The filing reports 57,929,733 shares outstanding for the issuer. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Jonathan Huberman, a director of CuriosityStream Inc. (CURI), reported sales of Common Stock on September 2 and September 4, 2025. On 09/02/2025 he sold 15,807 shares at a weighted average price of $4.6024, and on 09/04/2025 he sold 25,000 shares at a weighted average price of $4.5507. After the reported transactions, the filing shows 1,333,576 shares beneficially owned by Mr. Huberman indirectly through 211 LV LLC. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Huberman.
The filing discloses that the reported prices are weighted averages from multiple transactions within stated ranges and that Mr. Huberman may be deemed to share beneficial ownership of the securities held by 211 LV LLC while disclaiming beneficial ownership beyond any pecuniary interest.
Insider sales by CuriosityStream CFO under a Rule 10b5-1 plan. P. Brady Hayden, Chief Financial Officer, reported sales of common stock under a pre-established 10b5-1 plan entered May 30, 2025. On 08/29/2025 he sold 35,578 shares at a weighted average price of $4.414 and, on 09/02/2025, he sold 16,149 shares at $4.56. The filing states those sales were executed in multiple tranches at prices ranging from $4.24 to $4.64. After the reported 08/29 sale Mr. Hayden beneficially owned 54,474 shares (indirectly via the P. Brady Hayden Revocable Trust) and after the 09/02 sale he beneficially owned 38,325 shares. He also beneficially owns 25,000 shares held by Plan Z, LLC, of which he is the managing member.
Jonathan Huberman, a director of CuriosityStream Inc. (CURI), reported sales of company common stock on 08/29/2025. The filing discloses dispositions of 40,057 shares sold at a weighted-average price of $4.494 (individual trades ranged from $4.45 to $4.64) and an additional reported disposition of 144,700 shares. After these transactions, the reporting person beneficially owned 1,374,383 shares indirectly through 211 LV LLC, for which he is the managing member and which may result in shared beneficial ownership. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Huberman.
CuriosityStream Inc. (CURI) Form 144 summary: An individual beneficiary or account related to the filer plans to sell 16,149 common shares on or about 09/02/2025 through Fidelity Brokerage Services (NASDAQ). The filing reports an aggregate market value of $73,639.44 and notes these shares were acquired on 08/14/2024 via restricted stock vesting as compensation. The filer also reported a prior sale by the P. Brady Hayden Revocable Trust of 35,578 shares on 08/29/2025 for $156,774.64. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for CuriosityStream, Inc. (CURI) reports a proposed sale of 50,000 common shares through Needham and Company LLC with an aggregate market value of $230,000.00, and lists the number of shares outstanding as 57,929,733. The shares were acquired on 10/14/2020 via a SPAC conversion. The filing also discloses that the same beneficial owner sold the full 50,000 shares across four transactions dated 08/25/2025, 08/26/2025, 08/27/2025, and 08/29/2025 for total gross proceeds of approximately $222,525.54. The filer certifies no undisclosed material adverse information.